Results 101 to 110 of about 1,561,331 (181)

A Summary for Non-Psychiatrists of the Australian and New Zealand Journal of Psychiatry Grading of Recommendations, Assessment, Development and Evaluations (GRADE) Guidelines for the Management of Schizophrenia. [PDF]

Med J Aust
Suetani S, Dark F, Every-Palmer S, Galletly C, O'Donoghue B, Halstead S, Keating D, Kisely S, Korman N, Lappin J, Lawn S, Thompson A, Warren N, Siskind DJ.   +13 more
europepmc   +1 more source

Neuropsychiatric Effects of Glucagon-Like Peptide-1 Receptor Agonists in Schizophrenia-Spectrum Disorders: A Systematic Review. [PDF]

Cureus
Alsanosi ZY, Alshahrani AS, Nammazi AA, Alsunusi OA, Moafa AA, Hadi IH, Alabdali AA, Alhaqbani AW, Shahat RA, Albeladi SA, Almajdoa AA.   +10 more
europepmc   +1 more source

Real-world antipsychotic prescribing patterns and mortality in schizophrenia: a registry cohort study from China. [PDF]

Epidemiol Psychiatr Sci
He H, Dai L, Ma S, Jia FJ, Chen B, Lin H, Wang SB, Tan W, Li J.   +8 more
europepmc   +1 more source

Adverse effect MonoPoly: Antipsychotic monopharmacy vs antipsychotic polypharmacy in the treatment of schizophrenia. [PDF]

Indian J Psychiatry
Singh S, Shenoy S, Praharaj SK.
europepmc   +1 more source

Acute Laryngeal Dystonia Mimicking Anaphylaxis Following Antipsychotic Initiation: A Case Report. [PDF]

Case Rep Psychiatry
Wadhwa D.
europepmc   +1 more source

Antipsychotic agents.

North Carolina medical journal, 1974
openaire   +1 more source

FR - Actualización en el tratamiento de los principales trastornos psicodermatológicos

Actas Dermo-Sifiliográficas
O. Alwattar-Ceballos, L. Martínez-Montalvo, F. Moro-Bolado   +2 more
doaj   +1 more source